氪諾思生醫股份有限公司
Update：2026/11/10
Industries
Main Industry
Health Care
Main Product/Service
We provide breath metabolomics testing and gas analysis services, integrating GC-IMS and AI models for disease and metabolic research. We support clinical trials, drug development, and health monitoring, while also developing novel gas sensing equipment and sampling modules paired with data analysis and cloud AI platform applications.
The content above was translated by Ai
Founded Year
2025
Unified Business No.
60777135
Status
Active
Number of Employees
3
Total Paid-in
Capital
4,380,000 (NT$)
Location of Company
Taiwan
, Taipei City
Website
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
氪諾思生醫股份有限公司 takes odor science and breath metabolomics as its core, combining gas analysis, artificial intelligence training, and clinical data integration to establish a high-dimensional metabolic data platform and build a non-invasive intelligent detection system, which is applied to clinical diagnosis, drug metabolism research and development, and health management.
The content above was translated by Ai
